180 related articles for article (PubMed ID: 15710358)
21. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
22. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
[TBL] [Abstract][Full Text] [Related]
23. UV-inducible base excision repair of oxidative damaged DNA in human cells.
Kassam SN; Rainbow AJ
Mutagenesis; 2009 Jan; 24(1):75-83. PubMed ID: 18836099
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair.
Toyooka T; Ibuki Y
Cancer Res; 2009 Apr; 69(8):3492-500. PubMed ID: 19351858
[TBL] [Abstract][Full Text] [Related]
25. Topical thymidine dinucleotide application protects against UVB-induced skin cancer in mice with DNA repair gene (Ercc1)-deficient skin.
Lawrence NJ; Song L; Doig J; Ritchie AM; Brownstein DG; Melton DW
DNA Repair (Amst); 2009 May; 8(5):664-71. PubMed ID: 19264557
[TBL] [Abstract][Full Text] [Related]
26. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
Wiltshire T; Senft J; Wang Y; Konat GW; Wenger SL; Reed E; Wang W
Mol Pharmacol; 2007 Apr; 71(4):1051-60. PubMed ID: 17229870
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.
Pepper C; Lowe H; Fegan C; Thurieau C; Thurston DE; Hartley JA; Delavault P
Br J Cancer; 2007 Jul; 97(2):253-9. PubMed ID: 17579621
[TBL] [Abstract][Full Text] [Related]
28. Apoptogenic activity of a synthetic cantharimide in leukaemia: implication on its structural activity relationship.
Kok SH; Chui CH; Lam WS; Chen J; Lau FY; Wong RS; Cheng GY; Tang WK; Teo IT; Cheung F; Cheng CH; Chan AS; Tang JC
Int J Mol Med; 2006 Dec; 18(6):1217-21. PubMed ID: 17089029
[TBL] [Abstract][Full Text] [Related]
29. Regulation of DNA repair gene expression in human cancer cell lines.
McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
[TBL] [Abstract][Full Text] [Related]
30. Suppression of a DNA base excision repair gene, hOGG1, increases bleomycin sensitivity of human lung cancer cell line.
Wu M; Zhang Z; Che W
Toxicol Appl Pharmacol; 2008 May; 228(3):395-402. PubMed ID: 18234257
[TBL] [Abstract][Full Text] [Related]
31. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
32. An in vivo analysis of MMC-induced DNA damage and its repair.
Lee YJ; Park SJ; Ciccone SL; Kim CR; Lee SH
Carcinogenesis; 2006 Mar; 27(3):446-53. PubMed ID: 16258176
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines.
Gambi N; Tramontano F; Quesada P
Biochem Pharmacol; 2008 Jun; 75(12):2356-63. PubMed ID: 18468580
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
[TBL] [Abstract][Full Text] [Related]
35. Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells.
Holt SM; Scemama JL; Panayiotidis MI; Georgakilas AG
Mutat Res; 2009 Mar; 674(1-2):123-30. PubMed ID: 18955159
[TBL] [Abstract][Full Text] [Related]
36. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress induction by T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway in human cervical cancer cells.
Chaudhari M; Jayaraj R; Bhaskar AS; Lakshmana Rao PV
Toxicology; 2009 Aug; 262(2):153-61. PubMed ID: 19524637
[TBL] [Abstract][Full Text] [Related]
38. Compound K suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair in human keratinocytes.
Cai BX; Luo D; Lin XF; Gao J
Arch Pharm Res; 2008 Nov; 31(11):1483-8. PubMed ID: 19023546
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis on carcinoma cells by two synthetic cantharidin analogues.
Kok SH; Chui CH; Lam WS; Chen J; Tang JC; Lau FY; Cheng GY; Wong RS; Chan AS
Int J Mol Med; 2006 Jan; 17(1):151-7. PubMed ID: 16328024
[TBL] [Abstract][Full Text] [Related]
40. Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma.
Verma AK; Prasad SB
Cell Biol Toxicol; 2012 Jun; 28(3):133-47. PubMed ID: 22402807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
